SwePub
Sök i LIBRIS databas

  Extended search

(WFRF:(Kotseva K))
 

Search: (WFRF:(Kotseva K)) > (2008-2009) > Treatment potential...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003454naa a2200385 4500
001oai:lup.lub.lu.se:7bfbc0e8-c8e6-41e2-ba66-1aa493315a73
003SwePub
008160401s2008 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/12053802 URI
024a https://doi.org/10.1016/j.atherosclerosis.2007.07.0042 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Kotseva, K4 aut
2451 0a Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: Findings from the EUROASPIRE II survey
264 1b Elsevier BV,c 2008
520 a Background: During the last decade, the evidence of beneficial effects of cholesterol lowering in patients with coronary heart disease (CHD) has been proven in several clinical trials. This has prompted international guidelines on prevention of CHD to include recommendations on dietary and pharmacological treatment of hyperlipidaernia with set goals on total- and LDL-cholesterol. Methods: The first EUROASPIRE survey performed in 1995/1996 showed poor adherence to the European recommendations on lipid-lowering in patients with CHD. The second survey was carried out in 1999/2000 in 15 European countries and enrolled 8181 patients with CHD. Medical records were assessed and clinical examinations of risk factors including serum lipids were performed. The aim of this survey is to describe the treatment of hyperlipidaemia among CHD patients in Europe. Results: The proportion of patients not reaching the target of 5.0 mmol/l was 58.3% with significant variations between countries. The use of lipid-lowering drugs was relatively high (60.9%). However, the most frequently used doses of lipid-lowering agents were much lower than the doses of proven effect used in clinical trials. Conclusions: Although the treatment of hyperlipidaemia in CHD patients seems to be improving as compared to the first survey, a significant number of patients do not reach treatment goals. If the full potential of lipid-lowering therapy was utilised with all eligible patients treated and doses titrated correctly, more patients would benefit in terms of reduced morbidity and mortality of CHD. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
653 a guidelines
653 a EUROASPIRE
653 a coronary heart disease
653 a secondary prevention
653 a hyperlipidaemia
700a Stagmo, Martinu Lund University,Lunds universitet,Kardiologiska klinikens forskargrupp,Forskargrupper vid Lunds universitet,Cardiology Research Group,Lund University Research Groups4 aut0 (Swepub:lu)medf-ms0
700a De Bacquer, D4 aut
700a De Backer, G4 aut
700a Wood, D4 aut
710a Kardiologiska klinikens forskargruppb Forskargrupper vid Lunds universitet4 org
773t Atherosclerosisd : Elsevier BVg 197:2, s. 710-717q 197:2<710-717x 1879-1484x 0021-9150
856u http://dx.doi.org/10.1016/j.atherosclerosis.2007.07.004y FULLTEXT
8564 8u https://lup.lub.lu.se/record/1205380
8564 8u https://doi.org/10.1016/j.atherosclerosis.2007.07.004

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Kotseva, K
Stagmo, Martin
De Bacquer, D
De Backer, G
Wood, D
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Cardiac and Card ...
Articles in the publication
Atherosclerosis
By the university
Lund University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view